Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2006

01-09-2006 | Letter to the editor

Rituximab as first line treatment for MALT lymphoma of extraocular muscles

Authors: Leonidas Benetatos, Vasiliki Alymara, Ioannis Asproudis, Konstantinos L. Bourantas

Published in: Annals of Hematology | Issue 9/2006

Login to get access

Excerpt

To the editor: …
Literature
1.
Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, Shin SO, Cho HS, Bae SH, Ryoo HM (2005) Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Ann Hematol 84:13–18PubMedCrossRef
2.
3.
Nuckel H, Meller D, Steuhl KP, Duhrsen U (2004) Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 73:258–262PubMedCrossRef
4.
Morgensztern D, Rosado MF, Serafini AN, Lossos IS (2004) Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Leuk Lymphoma 45:1275–1278PubMedCrossRef
5.
Asproudis I, Gorezis S, Charonis GC, Tolis C, Tsanou E, Agnantis NJ (2005) Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland—a case report. In Vivo 19:1105–1109PubMed
6.
Rosado MF, Byrne GE Jr, Ding F, Fields KA, Ruiz P, Dubovy SR, Walker GR, Markoe A, Lossos IS (2006) Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 107:467–472PubMedCrossRef
Metadata
Title
Rituximab as first line treatment for MALT lymphoma of extraocular muscles
Authors
Leonidas Benetatos
Vasiliki Alymara
Ioannis Asproudis
Konstantinos L. Bourantas
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 9/2006
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-006-0134-0

Other articles of this Issue 9/2006

Annals of Hematology 9/2006 Go to the issue

Erratum

Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Abstracts

7th International Lübeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factors

Original Article

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma

Letter to the Editor

Transient severe symptomatic pulmonary hypertension as onset symptom in multiple myeloma

Original Article

Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A)

Letter to the Editor

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits